Anjali Sud - 03 Feb 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Anjali Sud
Issuer symbol
DLB
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
4
Filing time
05 Feb 2026, 19:44:28 UTC
Previous filing
25 Nov 2025
Next filing
02 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sud Anjali Director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO /s/ Daniel Rodriguez as Attorney-in-Fact for Anjali Sud 05 Feb 2026 0001775509

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Award $0 +3,908 +32% $0.000000 16,079 03 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
F2 Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.